Release Date: 20/08/18 09:53 Summary: Asset acquisition of Brazilian mobile commerce business unit Price Sensitive: Yes Download Document 422.44KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%